Gastrointestinal prostheses

• US 9,044,300 B2
• Filed: 04/03/2014
• Issued: 06/02/2015
• Est. Priority Date: 04/03/2009
• Status: Active Grant

• Current Assignee: MetaModix, Inc.
• Original Assignee: MetaModix, Inc.
• Inventors: Belhe, Kedar R., Thompson, Paul J.
• Primary Examiner(s): Wiest, Philip R
• Application Number:
  US14/244,544
• Publication Number:
  US 20140213960A1
• Time in Patent Office: 425 Days
• Field of Search: 604/8, 604/9, 604/192, 623 2364- 2368
• US Class Current: 1/1
• CPC Class Codes: A61F 2002/044 Oesophagi or esophagi or gullets
• CPC Class Codes: A61F 2002/045 Stomach, intestines
• CPC Class Codes: A61F 5/0076 preventing normal digestion, e.g. Bariatric or gastric sleeves
• CPC Class Codes: A61F 5/0079 Pyloric or esophageal obstructions

Abstract

A system for therapy within a gastrointestinal system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This design allows the physician to tailor the therapy to the patient'"'"'s needs. The system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM.

Claims

1. An implant for treating metabolic disorders such as diabetes and obesity, the implant having an unconstrained state comprising:

an anchoring element including a self-expandable structure having;

a first portion that has a first diameter in the unconstrained state that is configured for engaging a first wall of the pylorus at a first location adjacent the pyloric antrum;

a second portion that has a second diameter in the unconstrained state that is configured for engaging a second wall of the pylorus at a second location adjacent the duodenal bulb; and

a neck portion located between the first portion and the second portion that is adapted to extend through and engage an inner surface of the pylorus in the unconstrained state, the neck portion in the unconstrained state having a third diameter that is less than the first diameter and less than the second diameter but equal to or larger than a maximum diameter of the pylorus, such that the neck portion does not restrict flow through the pylorus,

wherein at least one of the first portion and the second portion in the unconstrained state defines an increasing diameter as it extends away from the neck portion; and

a therapy implant adapted for placement within the duodenum, the therapy implant coupled to the anchoring element, such that the therapy implant does not penetrate into the duodenal bulb.

2. The implant of claim 1 wherein the second portion of the anchoring element has an unconstrained diameter smaller than a duodenal bulb diameter, such that the second portion would not contact the duodenal bulb upon implantation.

3. The implant of claim 1 wherein the neck portion is made from a flexible material configured to at least partially collapse in response to a radial force typically applied by a pylorus to allow closing of the pylorus.

12. The implant of claim 1 wherein the anchoring element comprises a stent.

4. An implant for treating metabolic disorders such as diabetes and obesity, the implant having an unconstrained state comprising:

an anchoring element including an expandable structure having;

a first portion that has a first diameter in the unconstrained state and is configured for positioning within the pyloric antrum and for engaging a proximal wall of the pylorus;

a second portion that has a second diameter in the unconstrained state and is configured for positioning within the duodenum and for engaging a distal wall of the pylorus; and

a neck portion located between the first portion and the second portion that is adapted to extend through and engage an inner surface of the pylorus in the unconstrained state, the neck portion having a third diameter that is less than the first diameter and less than the second diameter but equal to or larger than a maximum diameter of the pylorus, such that the neck portion does not restrict flow through the pylorus,

wherein at least one of the first portion and the second portion in the unconstrained state defines an open interior chamber, and wherein the anchoring element in the unconstrained state allows opening and closing of the pylorus; and

a therapy implant adapted for placement within the duodenum, the therapy implant having a length such that it extends into the duodenum or proximal jejunum;

wherein neither of the anchoring element or the therapy implant penetrate into or exert a radial force upon the duodenal bulb upon implantation of the implant.

5. The implant of claim 4 wherein the therapy implant comprises a sleeve element that extends into the duodenum or the proximal jejunum.

6. The implant of claim 4 wherein the neck portion is made from a flexible material configured to at least partially collapse in response to a radial force typically applied by a pylorus to allow closing of the pylorus.

7. The implant of claim 4 wherein the second portion includes a plurality of circumferential openings and further wherein the therapy implant includes a plurality of circumferentially disposed protrusions configured to mate with the plurality of openings, such that the therapy implant is releasably coupled to the anchoring element to facilitate removal of the therapy implant.

8. The implant of claim 4 wherein the second portion of the anchoring element has an unconstrained diameter smaller than a duodenal bulb diameter, such that the second portion would not contact the duodenal bulb upon implantation.

13. The implant of claim 4 wherein the anchoring element comprises a stent.

9. An implant for treating metabolic disorders such as diabetes and obesity, the implant having an unconstrained state comprising:

an anchoring element including an expandable structure having;

a first portion that has a first diameter in the unconstrained state and is configured for positioning within the pyloric antrum and for engaging a proximal wall of the pylorus;

a second portion that has a second diameter in the unconstrained state and is configured for positioning within the duodenum and for engaging a distal wall of the pylorus; and

a neck portion located between the first portion and the second portion that is adapted to extend through and engage an inner surface of the pylorus in the unconstrained configuration, the neck portion in the unconstrained configuration having a third diameter that is less than the first diameter and less than the second diameter but equal to or larger than a maximum diameter of the pylorus, such that the neck portion does not restrict flow through the pylorus,

wherein the first diameter is less than a corresponding pyloric antrum diameter and the second diameter is less than a corresponding duodenal diameter, and wherein the anchoring element in the unconstrained state does not include any structure disposed within the diameter of the neck portion; and

a therapy implant adapted for placement within the duodenum, the therapy implant having a length such that it extends into the duodenum or proximal jejunum;

wherein neither of the anchoring element or the therapy implant penetrate into or exert a radial force sufficient to anchor the anchoring element or the therapy implant within the duodenal bulb.

10. The implant of claim 9 wherein the first portion is disk-shaped.

11. The implant of claim 9 wherein the first portion has an unconstrained outer diameter that is smaller than a diameter of the pyloric antrum, such that the unconstrained outer diameter of the first portion would not contact the pyloric antrum upon implantation.

14. The implant of claim 9 wherein the anchoring element comprises a stent.